Join us this March for the first ever CURE Patient-Focused Sessions, taking place at the Miami Breast Cancer Conference! 

×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer. 
Katie Kosko
The Food and Drug Administration has approved Nplate for pediatric patients 1 year of age and older with immune thrombocytopenia who have had an insufficient response to medications, such as corticosteroids,or surgery to remove the spleen. 
ARLENE WEINTRAUB
Men with advanced prostate cancer may benefit from genomic testing as BRCA and other gene mutations play a bigger role in guiding treatment.
More

Voices

Dana Stewart
Instead of fighting the roadblocks that cancer can prevent, what would happen if we embraced them?
Martha Carlson
Cancer has led me to men and women who grabbed onto life but died anyway.
Jane Biehl, Ph.D.
I try so hard to be positive, but in the back of my mind, I am constantly waiting for the other shoe to drop, for my blood counts to worsen, for the results of the next bone marrow biopsy to be haywire, for the chemo with its side effects to be administered, intensified or changed.
More

CURE Connections®

Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, provide their perspectives on adjusting to life with cancer of the head and neck, as a patient or as a caregiver, and share advice for those who must undergo laryngectomy. 
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, share insight into the role of novel treatment approaches like immunotherapy, robotic surgery and de-escalation in the management of cancers of the head and neck.
Meryl Kaufman, M.Ed., CCC-SLP, BRS-S, and Itzhak Brook, M.D., M.Sc., board members of the Head and Neck Cancer Alliance, review the various modalities of treatment for cancers of the head and neck and identify which physicians are responsible for delivering this care.
More

Videos

Two dietitians discuss the important role that food and nutrition play from diagnosis to survivorship.
Peter Voorhees, M.D.
New findings could spark change in the way that some patients with multiple myeloma are treated.
Matthew Yurgelun, M.D.
There can be many benefits for patients with gastrointestinal cancers, as well as their loved ones, to undergo genetic testing.
More

Podcasts

Kristie L. Kahl
This week, we spoke with three sisters with a long family history of the BRCA gene mutation – one that dates back to 1860 in Poland.
Kristie L. Kahl
This week, we spoke with former NFL coach, motivational speaker and acute promyelocytic leukemia survivor Chuck Pagano about his journey with cancer, and what has inspired him to give back following his diagnosis.
Brielle Benyon
For this episode of the CURE Talks Cancer podcast, we spoke with Scott Hamilton, an Olympic gold medalist, cancer survivor and founder of the Scott Hamilton CARES Foundation
More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other